You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data

found 2025 › Aug › 26 (Tue) @ 20:35 UTC

Healthy ■■
Eli Lilly ■■
Eli ■■
Lilly ■■
Daniel Skovronsky ■■
UnitedHealth Group ■■
Stephen Hemsley ■■

Eli Lilly's Daniel Skovronsky talks the latest orforglipron trial, while UnitedHealth Group CEO Stephen Hemsley is moving quickly on a strategic turnaround.